NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017.

نویسندگان

Arnel Pallera

Jessica K Altman

Ellin Berman

Camille N Abboud

Bhavana Bhatnagar

Peter Curtin

Daniel J DeAngelo

Jason Gotlib

R Tanner Hagelstrom

Gabriela Hobbs

Madan Jagasia

Hagop M Kantarjian

Patricia Kropf

Leland Metheny

Joseph O Moore

Evelena Ontiveros

Enkhtsetseg Purev

Albert Quiery

Vishnu V B Reddy

Michal G Rose

Neil P Shah

B Douglas Smith

David S Snyder

Kendra L Sweet

Raoul Tibes

David T Yang

Kristina Gregory

Hema Sundar

Michael Deininger

Jerald P Radich

چکیده

The NCCN Guidelines for Chronic Myeloid Leukemia (CML) provide recommendations for the management of chronic-phase and advanced-phase CML in adult patients. The median age of disease onset is 67 years. However, because CML occurs in all age groups, clinical care teams should be prepared to address issues relating to fertility and pregnancy with patients who are of reproductive age at the time of diagnosis. CML is relatively rare in children and there are no evidence-based recommendations for the management of CML in pediatric population. These NCCN Guidelines Insights discuss special considerations for the management of CML during pregnancy and for the management of CML in the pediatric population.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

NCCN Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2017.

The prognosis for patients with newly diagnosed acute lymphoblastic leukemia (ALL) has improved with the use of more intensive chemotherapy regimens, tyrosine kinase inhibitors, targeted agents, and allogeneic hematopoietic cell transplantation. However, the management of relapsed or refractory (R/R) ALL remains challenging and prognosis is poor. The NCCN Guidelines for ALL provide recommendati...

متن کامل

Acute myeloid leukemia, version 2.2013.

These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Acute Myeloid Leukemia and discuss the clinical evidence that support the recommendations. The updates described in this article focus on the acute promyelocytic leukemia (APL) section, featuring recommendations for additional induction/consolidation regimens in patients with low- or intermediate-risk APL, a...

متن کامل

Myelodysplastic syndromes, version 2.2015.

The NCCN Guidelines for Myelodysplastic Syndromes (MDS) comprise a heterogeneous group of myeloid disorders with a highly variable disease course that depends largely on risk factors. Risk evaluation is therefore a critical component of decision-making in the treatment of MDS. The development of newer treatments and the refinement of current treatment modalities are designed to improve patient ...

متن کامل

NeeD fOR gUIDelINes IN DIseAse MANAgeMeNT AND TReATMeNT

ABSTRACT Clinical practice guidelines are developed to improve the quality of care and outcomes for patients. Guidelines facilitate clinical decisions, promote efficient use of health care resources, and provide guidance to practitioners. For chronic myeloid leukemia (CML), tyrosine kinase inhibitors (TKIs) have changed the paradigm of therapy by lowering the disease burden and by providing mor...

متن کامل